Whole brain radiotherapy after local treatment of brain metastases in melanoma patients - a randomised phase III trial
<p>Abstract</p> <p>Background</p> <p>Cerebral metastases are a common cause of death in patients with melanoma. Systemic drug treatment of these metastases is rarely effective, and where possible surgical resection and/or stereotactic radiosurgery (SRS) are the preferre...
Main Authors: | Forder Peta M, Mandel Catherine, Nowak Anna K, Vardy Janette, Morton Rachael L, Fogarty Gerald, Hong Angela, Hruby George, Burmeister Bryan, Shivalingam Brindha, Dhillon Haryana, Thompson John F |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2011-04-01
|
Series: | BMC Cancer |
Online Access: | http://www.biomedcentral.com/1471-2407/11/142 |
Similar Items
-
Whole brain radiotherapy (WBRT) after local treatment of brain metastases in melanoma patients: Statistical Analysis Plan
by: Serigne N. Lo, et al.
Published: (2019-08-01) -
Phase‐3 international trial of adjuvant whole brain radiotherapy (WBRT) or observation (Obs) following local treatment of 1‐3 melanoma brain metastases (MBMs)
by: Fogarty, GB, et al.
Published: (2019) -
Longitudinal trajectory of quality of life for patients with melanoma brain metastases: A secondary analysis from a whole brain radiotherapy randomized clinical trial
by: Iris Bartula, et al.
Published: (2023-07-01) -
Single institutional outcomes of whole brain radiotherapy for metastatic melanoma brain metastases
by: Cecilia Jiang, et al.
Published: (2021-02-01) -
Real world outcomes of combination and timing of immunotherapy with radiotherapy for melanoma with brain metastases
by: Justin T. Moyers, et al.
Published: (2021-02-01)